Literature DB >> 18482000

Gene expression is reduced in trans by inosine-containing dsRNA.

A D J Scadden1.   

Abstract

Inosine residues may be introduced into long dsRNA (double-stranded RNA) molecules by the action of a family of editing enzymes, ADARs (adenosine deaminases that act on RNA). Furthermore, hyperediting of dsRNA by ADARs may result in up to 50% of adenosine residues being converted into inosine. While the effect of hyperediting has traditionally been thought to be limited to the edited dsRNA, we have recently shown that hyperedited dsRNA [I-dsRNA (inosine-containing dsRNA)] is able to down-regulate the expression of both reporter and endogenous mRNAs in cells, in trans. Down-regulation by I-dsRNA occurs both by reducing mRNA levels and by inhibiting of translation. This finding has important functional consequences for hyperediting by ADARs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18482000     DOI: 10.1042/BST0360534

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  3 in total

1.  The RNA binding protein Tudor-SN is essential for stress tolerance and stabilizes levels of stress-responsive mRNAs encoding secreted proteins in Arabidopsis.

Authors:  Nicolas Frei dit Frey; Philippe Muller; Fabien Jammes; Dimosthenis Kizis; Jeffrey Leung; Catherine Perrot-Rechenmann; Michele Wolfe Bianchi
Journal:  Plant Cell       Date:  2010-05-18       Impact factor: 11.277

2.  Altered ADAR 2 equilibrium and 5HT(2C) R editing in the prefrontal cortex of ADAR 2 transgenic mice.

Authors:  M Singh; M M Singh; E Na; K Agassandian; M B Zimmerman; A K Johnson
Journal:  Genes Brain Behav       Date:  2011-06-13       Impact factor: 3.449

3.  Nuclease Tudor-SN Is Involved in Tick dsRNA-Mediated RNA Interference and Feeding but Not in Defense against Flaviviral or Anaplasma phagocytophilum Rickettsial Infection.

Authors:  Nieves Ayllón; Victoria Naranjo; Ondrej Hajdušek; Margarita Villar; Ruth C Galindo; Katherine M Kocan; Pilar Alberdi; Radek Šíma; Alejandro Cabezas-Cruz; Claudia Rückert; Lesley Bell-Sakyi; Mária Kazimírová; Sabína Havlíková; Boris Klempa; Petr Kopáček; José de la Fuente
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.